Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.3K
Overview
51.3K
Cancer Vaccines01:30

Cancer Vaccines

990
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
990
Sustainable Development01:43

Sustainable Development

14.8K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
14.8K
Development of the Lymphatic System01:15

Development of the Lymphatic System

2.0K
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
2.0K
Language Development01:22

Language Development

879
Children master language quickly and with relative ease, supported by both biological predisposition and reinforcement. B. F. Skinner (1957) proposed that language is learned through reinforcement, while Noam Chomsky (1965) argued that language acquisition mechanisms are biologically determined.
The critical period for language acquisition suggests that the ability to acquire language is at its peak early in life. As people age, this proficiency decreases. Language development begins very...
879
Development of the Heart01:27

Development of the Heart

2.3K
The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The OCTN2 transporter can be targeted by carnitine functionalised non-ionic surfactant vesicles to deliver drugs across the blood-brain barrier.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Revisiting the lipid ratio in lipid nanoparticles: A comparison of OFAT and design of experiments approaches.

Drug delivery and translational research·2026
Same author

Development and in vitro cellular evaluation of optimised multiple emulsion and liposomes-in-emulsion adjuvant systems for vaccine delivery.

International journal of pharmaceutics·2026
Same author

Analysis of bio-nano interactions by electrical asymmetric flow field-flow fractionation with multiple online detectors.

Journal of chromatography. A·2026
Same author

Impact of solvent choice during microfluidic manufacture on the in vivo performance of liposomal doxorubicin.

Drug delivery and translational research·2026
Same author

Camptothecin-Bearing PEGylated Polypropylenimine Dendriplexes for Prostate Cancer Gene Therapy: Impact of Microfluidic Processing on Physicochemical Properties and Transfection.

Pharmaceutics·2026
Same journal

Techniques of Mucilage and Gum Modification and their Effect on Hydrophilicity and Drug Release.

Recent patents on drug delivery & formulation·2020
Same journal

Oral Disintegrating Tablets - An Updated Patent Perspective.

Recent patents on drug delivery & formulation·2020
Same journal

Increasing Progenitor Cell Proliferation in the Sub-Ventricular Zone: A Therapeutic Treatment for Progressive Multiple Sclerosis?

Recent patents on drug delivery & formulation·2020
Same journal

Progresses and Challenges of Fast Dissolving/Disintegrating Dosage Forms in Manufacturing, Formulation Screening, Preclinical Testing and Drug Delivery.

Recent patents on drug delivery & formulation·2020
Same journal

Study and Development of an Anthroposophical Formula Based on <i>Phosphorus</i> and <i>Formica rufa</i> for Onychomycosis´s Treatment.

Recent patents on drug delivery & formulation·2020
Same journal

A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.

Recent patents on drug delivery & formulation·2020
See all related articles

Related Experiment Video

Updated: Jan 25, 2026

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
05:39

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

12.6K

Recent developments in particulate-based vaccines.

Yvonne Perrie1, Daniel Kirby, Vincent W Bramwell

  • 1Medicines Research Unit, School of Life and Health Sciences, University of Aston, Birmingham, UK. y.perrie@aston.ac.uk

Recent Patents on Drug Delivery & Formulation
|December 17, 2008
PubMed
Summary
This summary is machine-generated.

Particulate vaccine adjuvants, like polymer microspheres and cationic lipid vesicles, enhance vaccine efficacy and safety. Further research is needed to overcome challenges for clinical application of these novel adjuvant systems.

More Related Videos

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

17.5K
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.4K

Related Experiment Videos

Last Updated: Jan 25, 2026

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
05:39

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

12.6K
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

17.5K
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.4K

Area of Science:

  • Immunology
  • Vaccinology
  • Materials Science

Background:

  • Vaccine development faces a safety-efficacy trade-off, with subunit vaccines offering improved safety but reduced potency.
  • Current licensed adjuvant systems are limited, necessitating exploration of novel approaches.
  • Particulate systems present advantages for vaccine adjuvants, including targeted delivery and sustained release.

Purpose of the Study:

  • To review current particulate system technologies investigated as vaccine adjuvants.
  • To discuss the advantages and potential hurdles of these novel adjuvant systems for pharmaceutical development.

Main Methods:

  • Review of recent patents and scientific literature on particulate vaccine delivery systems.
  • Analysis of polymer-based microspheres and surfactant-based vesicles as potential adjuvants.
  • Evaluation of cationic lipids within particulate formulations for adjuvant potential.

Main Results:

  • Particulate systems offer passive targeting, protection from degradation, and sustained antigen release.
  • Polymer-based microspheres (especially polyesters) and surfactant-based vesicles are key patented formulations.
  • Cationic lipids show significant potential as adjuvants in particulate systems.

Conclusions:

  • Particulate vaccine delivery systems hold promise for enhancing adjuvant efficacy and safety.
  • Overcoming developmental hurdles is crucial for translating these technologies into successful pharmaceutical products.
  • Further investigation into polymer and lipid-based particulate adjuvants is warranted.